Canosimibe

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCanosimibe
Drug Alias NameAVE-5530
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesterol absorption inhibitors
TargetsNot applicable
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[25] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A